INGN - Inogen guides Q4 and FY22 revenue below consensus
-
Inogen ( NASDAQ: INGN ) estimates Q4 total revenue to be in the range of $87.5M to $88.5M, representing Y/Y growth of 14.5% to 15.8%, vs consensus of $89.48M .
-
FY22 total revenue is expected to be in the range of $376.7M to $377.7M, representing Y/Y growth of 5.2% to 5.5%, vs consensus of $378.55M .
-
Foreign exchange fluctuations are estimated to have a $1.3M and $5.3M impact on preliminary, unaudited 4Q22 and FY22 revenue respectively.
-
“...We expect productivity to improve in the near-term as the tenure of our DTC team increases and we continue partnering with our B2B channel to manage economic pressures. While we continue to prioritize investments to drive medium to long-term growth, we are also diligently managing operating expenses in support of our plans for long-term profitability,” said Nabil Shabshab, President and Chief Executive Officer.
-
Shares are trading down 1.44% premarket.
For further details see:
Inogen guides Q4 and FY22 revenue below consensus